The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback